Renal Disease Market Overview
The Renal Disease market is accruing and expected to gain further prominence over the forecast period mainly due to the growing prevalence of chronic Renal Disease, technological advancements and availability of effective treatments. According to a recent study report published by the Market Research Future, The global market of Renal Disease is projected to accrue at a rapid pace during the forecast period (2022 – 2030). The Market is forecasted to accrue USD 14291.2 Million with a striking CAGR of 11.20% during 2020 - 2030.
Renal disease also known as kidney diseases that affects the functioning of kidneys. According to National Kidney Foundation, Inc., 10% of world’s population is suffering from chronic kidney diseases. Global Renal Disease Market Research is growing moderately. The growing prevalence of renal diseases is leading the market growth. Increasing R&D activities and clinical trials are major driving forces of the market. Increasing acquaintance and awareness among the patients, growing healthcare sector, government initiatives and new product launches are key factors for the global renal disease market.
Most Renal diseases attack the nephrons. This damage may leave kidneys unable to remove wastes. Causes can include genetic problems, injuries, or medicines. Diabetics and high blood pressure patients have a higher risk of kidney disease. Chronic Renal disease damages the nephrons slowly over several years. A recent study also emphasises on Air pollution that could harm your kidneys. People with Renal Diseases are at increased risk of developing a life-threatening abnormal heart rhythm, a new report suggests. Chronic Renal disease can as much as double a patient's risk of atrial fibrillation, a quivering or irregular heartbeat that can lead to stroke or heart failure. The risk of atrial fibrillation increases as kidney function declines.
Renal Disease Market Segmentation
The Renal DiseaseMarket is segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;
Segmentation By Types : Comprises Acute Kidney Problems, Chronic Kidney Diseases, and other.
Segmentation By Diagnosis : Comprises Blood tests, Urine tests, Imaging tests, Removing a sample of kidney tissue for testing, and other.
Segmentation By Treatment: Comprises Medications, Dialysis, Kidney transplant, Surgery, Diet and others.
Segmentation By Regions : Comprises Geographical regions - North America, Europe, APAC and Rest of the World.
Renal Disease Market Regional Analysis
Considering the global scenario of the market, North America is believed to be the largest market for global renal disease. Moreover the European market is the second largest market for global renal disease and Western Europe region is the dominating the market in Europe. On the other hand, Asia-Pacific (APAC) is expected to grow at significant rate in the global renal disease market during the forecast period. Middle East and Africa (ME&A) is likely to have a limited growth in the market due to less awareness of disease and treatment.
A vague statistic indicates that 30 million American adults are likely to have chronic kidney disease and most aren't aware of it. 1 in 3 American adults are at risk for chronic kidney disease. Risk factors for kidney disease include diabetes, high blood pressure, heart disease, obesity and family history of kidney failure. People of African American, Hispanic, Native American, Asian or Pacific Islander descent are at increased risk for developing the disease. African Americans are 3 times more likely than Whites, and Hispanics are nearly 1.5 times more likely than non-Hispanics to develop end stage renal disease.
Renal Disease Market Players
· Abbott (US)
· Amgen Inc (US)
· AstraZeneca (US)
· Bristol-Myers Squibb Company (US)
· Hoffmann- La Roche Ltd (Switzerland)
· Fresenius Medical Care AG & Co., Ltd (Japan)
· Novartis AG (Switzerland)
· Pfizer Inc. (US)
· Sanofi SA (France) and
· Teva Pharmaceutical Industries Ltd (Israel)
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/renal-disease-market-3167
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 628 258 0071
Email: sales@marketresearchfuture.com
